banner banner banner banner banner banner

Upcoming events

XXI World Congress on Parkinson's Disease and Related Disorders
Sun 6 December - Wed 9 December 2015
Read more

Britannia at a glance

Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company.  We specialise in innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease.

Our key product Apomorphine Hydrochloride (Brand names: APO-go, APOKYN, Apomine) is a treatment for Parkinson’s disease which is available in many markets through our Distribution or Licensing Partners.

Click here to visit the apo go website; specifically there to help healthcare professionals, people with Parkinson's and their carers, as well as those who would like to understand more about APO-go (apomorphine).